Gut microbial function is altered in PD, characterized by differentially abundant metabolic features that provide important biological insights into gut-brain pathophysiology. Their clinical relevance further supports a role for microbial-metabolites as potential targets for the development of new biomarkers and therapies in PD. CLICK TO REVIEW